» Articles » PMID: 26489976

ADHD and Cannabis Use in Young Adults Examined Using FMRI of a Go/NoGo Task

Abstract

Children diagnosed with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for substance abuse. Response inhibition is a hallmark of ADHD, yet the combined effects of ADHD and regular substance use on neural networks associated with response inhibition are unknown. Task-based functional Magnetic Resonance Imaging (fMRI) data from young adults with childhood ADHD with (n = 25) and without (n = 25) cannabis use ≥ monthly in the past year were compared with a local normative comparison group (LNCG) with (n = 11) and without (n = 12) cannabis use. Go/NoGo behavioral and fMRI data were evaluated for main and interaction effects of ADHD diagnosis and cannabis use. ADHD participants made significantly more commission errors on NoGo trials than controls. ADHD participants also had less frontoparietal and frontostriatal activity, independent of cannabis use. No main effects of cannabis use on response inhibition or functional brain activation were observed. An interaction of ADHD diagnosis and cannabis use was found in the right hippocampus and cerebellar vermis, with increased recruitment of these regions in cannabis-using controls during correct response inhibition. ADHD participants had impaired response inhibition combined with less fronto-parietal/striatal activity, regardless of cannabis use history. Cannabis use did not impact behavioral response inhibition. Cannabis use was associated with hippocampal and cerebellar activation, areas rich in cannabinoid receptors, in LNCG but not ADHD participants. This may reflect recruitment of compensatory circuitry in cannabis using controls but not ADHD participants. Future studies targeting hippocampal and cerebellar-dependent function in these groups may provide further insight into how this circuitry is altered by ADHD and cannabis use.

Citing Articles

Effects of fMRI neurofeedback of right inferior frontal cortex on inhibitory brain activation in children with ADHD.

Lukito S, Lam S, Criaud M, Westwood S, Kowalczyk O, Curran S Philos Trans R Soc Lond B Biol Sci. 2024; 379(1915):20230097.

PMID: 39428885 PMC: 11491852. DOI: 10.1098/rstb.2023.0097.


Specificity in the commonalities of inhibition control: using meta-analysis and regression analysis to identify the key brain regions in psychiatric disorders.

Wan L, Pei P, Zhang Q, Gao W Eur Psychiatry. 2024; 67(1):e69.

PMID: 39397695 PMC: 11730059. DOI: 10.1192/j.eurpsy.2024.1785.


The Use of Compounds Derived from in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.

Stasilowicz-Krzemien A, Nogalska W, Maszewska Z, Maleszka M, Dobron M, Szary A Int J Mol Sci. 2024; 25(11).

PMID: 38891938 PMC: 11171823. DOI: 10.3390/ijms25115749.


Evaluation of Efficacy of Cannabis Use in Patients With Attention Deficit Hyperactivity Disorder: A Systematic Review.

Dhamija D, Bello A, Khan A, Gutlapalli S, Sohail M, Patel P Cureus. 2023; 15(6):e40969.

PMID: 37503496 PMC: 10370827. DOI: 10.7759/cureus.40969.


Meta-analysis of structural and functional alterations of brain in patients with attention-deficit/hyperactivity disorder.

Yu M, Gao X, Niu X, Zhang M, Yang Z, Han S Front Psychiatry. 2023; 13:1070142.

PMID: 36683981 PMC: 9853532. DOI: 10.3389/fpsyt.2022.1070142.


References
1.
Hester R, Nestor L, Garavan H . Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology. 2009; 34(11):2450-8. PMC: 2743772. DOI: 10.1038/npp.2009.67. View

2.
Glover G, Mueller B, Turner J, van Erp T, Liu T, Greve D . Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies. J Magn Reson Imaging. 2012; 36(1):39-54. PMC: 3349791. DOI: 10.1002/jmri.23572. View

3.
Casey B, Durston S . From behavior to cognition to the brain and back: what have we learned from functional imaging studies of attention deficit hyperactivity disorder?. Am J Psychiatry. 2006; 163(6):957-60. DOI: 10.1176/ajp.2006.163.6.957. View

4.
Roberts G, Garavan H . Evidence of increased activation underlying cognitive control in ecstasy and cannabis users. Neuroimage. 2010; 52(2):429-35. DOI: 10.1016/j.neuroimage.2010.04.192. View

5.
Dougherty D, Mathias C, Dawes M, Furr R, Charles N, Liguori A . Impulsivity, attention, memory, and decision-making among adolescent marijuana users. Psychopharmacology (Berl). 2012; 226(2):307-19. PMC: 3581724. DOI: 10.1007/s00213-012-2908-5. View